CVKD - Cadrenal Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 16.52M
Enterprise value 17.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-66.75%
S&P500 52-week change 33.90%
52-week high 36.7500
52-week low 31.2000
50-day moving average 31.4155
200-day moving average 31.7545

Share statistics

Avg vol (3-month) 341.03k
Avg vol (10-day) 314.91k
Shares outstanding 511.72M
Implied shares outstanding 6N/A
Float 83.14M
% held by insiders 169.49%
% held by institutions 10.00%
Shares short (14 May 2023) 481.18k
Short ratio (14 May 2023) 41.63
Short % of float (14 May 2023) 41.92%
Short % of shares outstanding (14 May 2023) 40.69%
Shares short (prior month 13 Apr 2023) 463.33k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-12.32M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.03M
Total cash per share (mrq)0.34
Total debt (mrq)38.33k
Total debt/equity (mrq)0.94
Current ratio (mrq)11.05
Book value per share (mrq)0.35

Cash flow statement

Operating cash flow (ttm)-2.68M
Levered free cash flow (ttm)N/A